These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 12109906

  • 1. Structure-based approach for binding site identification on AmpC beta-lactamase.
    Powers RA, Shoichet BK.
    J Med Chem; 2002 Jul 18; 45(15):3222-34. PubMed ID: 12109906
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
    Usher KC, Blaszczak LC, Weston GS, Shoichet BK, Remington SJ.
    Biochemistry; 1998 Nov 17; 37(46):16082-92. PubMed ID: 9819201
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.
    Powers RA, Swanson HC, Taracila MA, Florek NW, Romagnoli C, Caselli E, Prati F, Bonomo RA, Wallar BJ.
    Biochemistry; 2014 Dec 09; 53(48):7670-9. PubMed ID: 25380506
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The deacylation mechanism of AmpC beta-lactamase at ultrahigh resolution.
    Chen Y, Minasov G, Roth TA, Prati F, Shoichet BK.
    J Am Chem Soc; 2006 Mar 08; 128(9):2970-6. PubMed ID: 16506777
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
    Trehan I, Beadle BM, Shoichet BK.
    Biochemistry; 2001 Jul 10; 40(27):7992-9. PubMed ID: 11434768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
    Powers RA, Caselli E, Focia PJ, Prati F, Shoichet BK.
    Biochemistry; 2001 Aug 07; 40(31):9207-14. PubMed ID: 11478888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226.
    Ke W, Bethel CR, Papp-Wallace KM, Pagadala SR, Nottingham M, Fernandez D, Buynak JD, Bonomo RA, van den Akker F.
    Antimicrob Agents Chemother; 2012 May 07; 56(5):2713-8. PubMed ID: 22330909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.